Court Approval

RNS Number : 4870P

Surgical Innovations Group PLC

16 July 2010

 



Press Release

16 July 2010

Surgical Innovations Group plc

("SI" or "the Group")

 

 Court Approval   

Surgical Innovations Group plc (AIM: SUN), the designer and manufacturer of innovative surgical devices, is pleased to announce that on 15 July 2010, the Court approved its application for the cancellation of its share premium account through the offsetting of accumulated losses.

- Ends -

For further information:

Surgical Innovations Group plc
Doug Liversidge, Chairman	Tel: [phone]
	www.surginno.com
Graham Bowland, Chief Executive Officer	Tel: [phone]
[e-mail]	www.surginno.com

Westhouse Securities Limited
Tim Feather / Matthew Johnson	Tel: [phone]
[e-mail]	www.westhousesecurities.com

Media enquiries:

The Communications Portfolio
Ariane Comstive	Tel: [phone]
[e-mail]	www.communicationsportfolio.co.uk

Notes to Editors:

About Surgical Innovations Group plc

Surgical Innovations Group plc specialises in the design and manufacture of innovative devices for use in minimally invasive surgery and industrial markets.  The Group has two divisions; Surgical Innovations Limited and Haemocell Limited.

The Group employs over 100 people at its 32,000 square feet facility in Leeds, with in-house design and the manufacturing of products to the highest quality standards.  Through an established network of distribution partners, SI sells in all major medical markets including North America, Europe, South Africa, the Middle East, South-East Asia and Australia.

Surgical Innovations Limited, the main trading subsidiary of the Group, is focused on developing medical instruments for the laparoscopic surgery market - minimally invasive surgery of the abdomen.  The Group has pioneered Resposable® instrumentation combining both single use and reusable components ensuring an ongoing revenue stream and delivering the optimum procedure performance to cost ratio.  The Group's products include:

YelloPort+Plus®	A Resposable® laparoscopic port access system that combines both single-use and reusable components
Logi®Range	Resposable® laparoscopic instrumentation that combines both single-use and reusable components
Quick®Range	single-use instruments, with an ergonomic handle to ensure accurate control of the instrument. The range includes scissors, graspers and dissectors

In addition to its own branded instruments, the Group also designs and manufactures devices on an OEM basis for large medical device companies including Teleflex Medical, Gyrus, Olympus and CareFusion.

For more information, see www.surginno.com

 

END

 

 

MSCLLFLFDAIRLII